These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3812029)

  • 1. Malignant hypercalcemia--a hospital survey.
    Blomqvist CP
    Acta Med Scand; 1986; 220(5):455-63. PubMed ID: 3812029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Hypercalcemia in patients with malignant diseases and treatment with porcine calcitonin.
    Abe K; Adachi I
    Calcif Tissue Res; 1974; 15(2):153-4. PubMed ID: 4844388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
    Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P
    Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
    Theriault RL
    Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of the hypercalcemia of malignancy.
    Deftos LJ; Neer R
    Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of calcitonin in hypercalcemia in patients with malignancy.
    Vaughn CB; Vaitkevicius VK
    Cancer; 1974 Oct; 34(4):1268-71. PubMed ID: 4472732
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.
    Wright JD; Tergas AI; Ananth CV; Burke WM; Hou JY; Chen L; Neugut AI; Richards CA; Hershman DL
    Cancer Invest; 2015; 33(8):331-9. PubMed ID: 26068056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.
    Binstock ML; Mundy GR
    Ann Intern Med; 1980 Aug; 93(2):269-72. PubMed ID: 7406378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypercalcemia associated with malignancy.
    Mazzaferri EL; O'Dorisio TM; LoBuglio AF
    Semin Oncol; 1978 Jun; 5(2):141-53. PubMed ID: 150032
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR; Lipton A
    Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
    Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
    Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypercalcemia in neoplastic and granulomatous diseases: pathogenesis and treatment options].
    Igaz P; Tulassay Z
    Orv Hetil; 2005 Jul; 146(31):1631-4. PubMed ID: 16158612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone metastasis in advanced breast cancer].
    Adachi I; Suzuki M; Tsuchihashi T; Yamaguchi K; Abe K
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1688-95. PubMed ID: 2954509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.